Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning

Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning

Bibliographic Details
Main Authors: Nelson, Michelle H., Bowers, Jacob S., Bailey, Stefanie R., Diven, Marshall A., Fugle, Caroline W., Kaiser, Andrew D. M., Wrzesinski, Claudia, Liu, Bei, Restifo, Nicholas P., Paulos, Chrystal M.
Format: Online
Language:English
Published: BioMed Central 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754841/
Description
Summary:

Similar Items